Benzinga | Oct 27, 2021 06:16AM EDT

Atlantic Equities Upgrades Abbott Laboratories to Overweight, Announces $144 Price Target

Atlantic Equities analyst James Mainwaring upgrades Abbott Laboratories (NYSE:ABT) from Neutral to Overweight and announces $144 price target.